ReviewF1000Research2018

Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings.

Baba Psalm Duniya Inusa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.